FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect

Zhiwei Yao(Yanbian University), Xiaolong Fu(China General Nuclear Power Corporation (China))
Journal of the Association for Research in Otolaryngology
April 15, 2024
Cited by 3


Related Papers